Financhill
Back

Sarepta Therapeutics Vs. Viking Therapeutics Industry Stock Comparison

Sell
30

SRPT
Sarepta Therapeutics

Last Price:
110.51
Seasonality Move:
16.38%
Sell
37

VKTX
Viking Therapeutics

Last Price:
51.66
Seasonality Move:
50.47%
Sell
30
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $110.50. The Score for SRPT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics a Buy, Sell or Hold?

  • The current Viking Therapeutics [VKTX] share price is $51.63. The Score for VKTX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • VKTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $110.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.

VKTX Stock Price Chart

What is Viking Therapeutics's stock price today?

  • The Viking Therapeutics share price today is $51.63
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight selling pressure.

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.89 Sell
Relative Strength Index (14 RSI): 37.25 Sell
Chaikin Money Flow: 63193 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (112 - 129.78) Sell
Bollinger Bands (100): (119.81 - 143.67) Sell

VKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.17 Sell
Relative Strength Index (14 RSI): 35.36 Sell
Chaikin Money Flow: -1345527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.82 - 72.02) Sell
Bollinger Bands (100): (53.98 - 67.2) Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 109.13 Buy
20-day SMA: 118.88 Sell
50-day SMA: 122.22 Sell
200-day SMA: 130.09 Sell
8-day EMA: 110.76 Sell
20-day EMA: 116.02 Sell
50-day EMA: 122.15 Sell
200-day EMA: 126.16 Sell

VKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 52.82 Sell
20-day SMA: 62.98 Sell
50-day SMA: 63.98 Sell
200-day SMA: 62.08 Sell
8-day EMA: 53.87 Sell
20-day EMA: 59.08 Sell
50-day EMA: 61.8 Sell
200-day EMA: 55.62 Sell

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.85 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.72 per share.

Viking Therapeutics Earnings Growth & VKTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.50 per share.

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Viking Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):